These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29244201)

  • 41. Comparison of obsessive-compulsive disorder patients with and without comorbid putative obsessive-compulsive spectrum disorders using a structured clinical interview.
    du Toit PL; van Kradenburg J; Niehaus D; Stein DJ
    Compr Psychiatry; 2001; 42(4):291-300. PubMed ID: 11458303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Residential treatment outcomes for adolescents with obsessive-compulsive disorder.
    Leonard RC; Franklin ME; Wetterneck CT; Riemann BC; Simpson HB; Kinnear K; Cahill SP; Lake PM
    Psychother Res; 2016 Nov; 26(6):727-36. PubMed ID: 26308588
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Mindfulness-based interventions in obsessive-compulsive disorder: Mechanisms of action and presentation of a pilot study].
    Gasnier M; Pelissolo A; Bondolfi G; Pelissolo S; Tomba M; Mallet L; N'diaye K
    Encephale; 2017 Dec; 43(6):594-599. PubMed ID: 27887679
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial.
    Håland AT; Vogel PA; Lie B; Launes G; Pripp AH; Himle JA
    Behav Res Ther; 2010 Jun; 48(6):547-54. PubMed ID: 20359692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metacognitive therapy for obsessive-compulsive disorder: A case report.
    Melchior K; Franken IHA; van der Heiden C
    Bull Menninger Clin; 2018; 82(4):375-389. PubMed ID: 30589580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of eveningness in obsessive-compulsive symptoms: Cross-sectional and prospective approaches.
    Cox RC; Tuck B; Olatunji BO
    J Affect Disord; 2018 Aug; 235():448-455. PubMed ID: 29679897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ; Goodman WK; Leckman JF; Barr LC; Heninger GR; Price LH
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent Advances in the Study of Sleep in the Anxiety Disorders, Obsessive-Compulsive Disorder, and Posttraumatic Stress Disorder.
    Boland EM; Ross RJ
    Psychiatr Clin North Am; 2015 Dec; 38(4):761-76. PubMed ID: 26600107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder.
    Gershuny BS; Baer L; Parker H; Gentes EL; Infield AL; Jenike MA
    Depress Anxiety; 2008; 25(1):69-71. PubMed ID: 17318836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure and Response Prevention for Comorbid Symptoms of Obsessive-Compulsive Disorder and Psychogenic Movement Disorder.
    Gros DF; Allan NP; Haren WB
    Prim Care Companion CNS Disord; 2018 Aug; 20(4):. PubMed ID: 30152925
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does cognitive-behavioral therapy response among adults with obsessive-compulsive disorder differ as a function of certain comorbidities?
    Storch EA; Lewin AB; Farrell L; Aldea MA; Reid J; Geffken GR; Murphy TK
    J Anxiety Disord; 2010 Aug; 24(6):547-52. PubMed ID: 20399603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comorbid obsessive-compulsive personality disorder in obsessive-compulsive disorder (OCD): a marker of severity.
    Lochner C; Serebro P; van der Merwe L; Hemmings S; Kinnear C; Seedat S; Stein DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1087-92. PubMed ID: 21411045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing exposure and response prevention for OCD: a couple-based approach.
    Abramowitz JS; Baucom DH; Wheaton MG; Boeding S; Fabricant LE; Paprocki C; Fischer MS
    Behav Modif; 2013 Mar; 37(2):189-210. PubMed ID: 22619395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the 2016 US presidential election on OCD symptom presentation: A case illustration.
    Davis ML; McCann M; Goodman WK; Storch EA
    J Clin Psychol; 2018 May; 74(5):750-754. PubMed ID: 29528496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Obsessive-Compulsive Symptom Dimensions and Insomnia: Associations Among a Treatment-Seeking Veteran Sample.
    Raines AM; Franklin CL; Carroll MN
    J Cogn Psychother; 2019 Feb; 33(1):46-57. PubMed ID: 32746421
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Objective sleep patterns and severity of symptoms in pediatric obsessive compulsive disorder: a pilot investigation.
    Alfano CA; Kim KL
    J Anxiety Disord; 2011 Aug; 25(6):835-9. PubMed ID: 21570250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
    Centorrino F; Hennen J; Mallya G; Egli S; Clark T; Baldessarini RJ
    Hum Psychopharmacol; 2006 Apr; 21(3):189-93. PubMed ID: 16625524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of Intensive Cognitive Behaviour Therapy in a Residential Setting for People with Severe Obsessive Compulsive Disorder: A Large Open Case Series.
    Veale D; Naismith I; Miles S; Childs G; Ball J; Muccio F; Darnley S
    Behav Cogn Psychother; 2016 May; 44(3):331-46. PubMed ID: 26122913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Phobie à deux" and other reasons why clinicians do not apply exposure with response prevention in patients with obsessive-compulsive disorder.
    Moritz S; Külz A; Voderholzer U; Hillebrand T; McKay D; Jelinek L
    Cogn Behav Ther; 2019 Mar; 48(2):162-176. PubMed ID: 30064295
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Exposure Therapy with the Help of a Wearable Defibrillator Device used in the Treatment of Severe Obsessive-Compulsive Disorder and Congenital LQTS - An Example for Interdisciplinary Treatment].
    Sinowatz F; Jilek C; Cuntz U; Greetfeld M; Hopfner P; Pache J; Voderholzer U
    Psychother Psychosom Med Psychol; 2019 Feb; 69(2):87-93. PubMed ID: 29660751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.